DK1064009T4 - Use of extracts of iris plants and Cimicifuga racemosa and tectorigenin as estrogen-like organ selective drug without uterotropic effect - Google Patents
Use of extracts of iris plants and Cimicifuga racemosa and tectorigenin as estrogen-like organ selective drug without uterotropic effectInfo
- Publication number
- DK1064009T4 DK1064009T4 DK99913282T DK99913282T DK1064009T4 DK 1064009 T4 DK1064009 T4 DK 1064009T4 DK 99913282 T DK99913282 T DK 99913282T DK 99913282 T DK99913282 T DK 99913282T DK 1064009 T4 DK1064009 T4 DK 1064009T4
- Authority
- DK
- Denmark
- Prior art keywords
- tectorigenin
- estrogen
- extracts
- cimicifuga racemosa
- selective drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament for selectively treating and/or for the prophylaxis of cardiovascular diseases, especially arteriolosclerosis, osteoporosis and climacteric symptoms, for example, for preventing or alleviating hot flashes. Virtually no uterotropic effects are observed when using said abstracts.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19812204A DE19812204A1 (en) | 1998-03-19 | 1998-03-19 | Use of extracts from Cimicifuga racemosa and Belamcanda sinensis as an estrogen-like organ-selective drug without uterotropic effects |
PCT/EP1999/001860 WO1999047149A1 (en) | 1998-03-19 | 1999-03-19 | Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1064009T3 DK1064009T3 (en) | 2002-11-04 |
DK1064009T4 true DK1064009T4 (en) | 2008-08-25 |
Family
ID=7861630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99913282T DK1064009T4 (en) | 1998-03-19 | 1999-03-19 | Use of extracts of iris plants and Cimicifuga racemosa and tectorigenin as estrogen-like organ selective drug without uterotropic effect |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1064009B2 (en) |
JP (2) | JP2002506827A (en) |
KR (1) | KR100623333B1 (en) |
CN (2) | CN100581541C (en) |
AT (1) | ATE225182T1 (en) |
AU (1) | AU755900C (en) |
BR (1) | BR9908256A (en) |
CA (1) | CA2321444C (en) |
CZ (1) | CZ292684B6 (en) |
DE (2) | DE19812204A1 (en) |
DK (1) | DK1064009T4 (en) |
ES (1) | ES2184427T5 (en) |
HK (1) | HK1035660A1 (en) |
HU (1) | HU227694B1 (en) |
MX (1) | MXPA00007986A (en) |
PL (1) | PL194096B1 (en) |
PT (1) | PT1064009E (en) |
RU (2) | RU2263505C2 (en) |
SE (1) | SE1064009T4 (en) |
TR (1) | TR200002686T2 (en) |
WO (1) | WO1999047149A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000302667A (en) * | 1999-04-23 | 2000-10-31 | Kobe Tennenbutsu Kagaku Kk | Accelerator for ample breasts |
AU7311501A (en) * | 2000-06-29 | 2002-03-22 | Quick Med Technologies Inc | Cosmetic composition and method |
TWI303990B (en) | 2000-10-17 | 2008-12-11 | Pfizer Prod Inc | New use of estrogen agonists/antagonists for improving vascular health |
DE10054641A1 (en) | 2000-11-03 | 2002-05-16 | Schaper & Bruemmer Gmbh | Use of a preparation of Cimicifuga racemosa |
DE10123503A1 (en) * | 2001-05-15 | 2002-11-21 | Bionorica Ag | Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia |
DE10127897B4 (en) * | 2001-06-08 | 2006-04-20 | Bionorica Ag | Coated tablet with dry plant extracts |
DE10146159A1 (en) * | 2001-09-19 | 2003-04-10 | Bionorica Ag | Use of extracts from Cimicifuga species as an organ-selective drug for the treatment of sex hormone-dependent diseases of the urogenital tract |
EP1325681A1 (en) * | 2001-12-11 | 2003-07-09 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health |
DE10206390A1 (en) * | 2002-02-15 | 2003-08-28 | Bionorica Ag | Use of phytoestrogen-containing extracts that selectively modulate the estrogen receptor beta |
JP4605984B2 (en) * | 2002-12-20 | 2011-01-05 | アサヒビール株式会社 | Stress relieving agent |
ATE427944T1 (en) * | 2003-05-15 | 2009-04-15 | Chengdu Dikang Pharmaceutical | ISOFLAVONE DERIVATIVES OF TECTORIDINE, THEIR PRODUCTION AND ANTIVIRAL MEDICATIONS CONTAINING SAME AS ACTIVE INGREDIENTS |
EP1588739A1 (en) * | 2004-04-23 | 2005-10-26 | Schaper & Brümmer Gmbh & Co. Kg | Composition comprising a combination of calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement |
EP1591143A1 (en) * | 2004-04-26 | 2005-11-02 | Schaper & Brümmer Gmbh & Co. Kg | Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement |
US7887851B2 (en) | 2004-06-07 | 2011-02-15 | Kao Corporation | Aromatase activator |
CN100381435C (en) * | 2005-03-24 | 2008-04-16 | 深圳海王药业有限公司 | Extractive of general flavone from blackberry lily, preparation method and application in preparing medication |
EP1745796A1 (en) | 2005-07-19 | 2007-01-24 | Bionorica Research GmbH | Compound preparation for treating prostate carcinoma |
CN101057854B (en) * | 2006-05-31 | 2010-05-12 | 南京大学 | Application of cycloartane type triterpenoids compound of cimicifuga rhizome for anti-osteoporosis and menopausal syndrome |
DE102007044916A1 (en) | 2007-09-19 | 2009-04-23 | Bionorica Ag | Cosmetic or dermatological composition for topical use |
KR100928013B1 (en) * | 2008-01-25 | 2009-11-24 | 이화여자대학교 산학협력단 | Method for improvement in growth of Echinochola crusgalli using Belamcanda chinensis extract and method for remediation of heavy-metal contaminated soil using the method |
CN101797265A (en) * | 2010-04-09 | 2010-08-11 | 中国人民解放军第二军医大学 | Application of belamcanda chinensis total isoflavone or isoflavone compounds in preparing medicaments and food for preventing and treating women's disease |
EP2545932A1 (en) | 2011-07-12 | 2013-01-16 | Bionorica Se | Selected cimicifuga fractions for treating osteoporosis |
WO2013007807A1 (en) | 2011-07-12 | 2013-01-17 | Bionorica Se | Selected cimicifuga fractions for the treatment of osteoporosis |
EP2620155A1 (en) | 2012-01-30 | 2013-07-31 | Bionorica SE | Medicine containing Cimicifuga for use in the treatment of sarcopenia and myocardial weakness |
CN102525907B (en) * | 2012-02-22 | 2013-06-05 | 四川省中医药科学院 | Tectorigenin sodium sulfonate injection |
CN102631363A (en) * | 2012-04-11 | 2012-08-15 | 李超生 | Application of tectoridin in preparing medicine for preventing osteoporosis |
KR20150018831A (en) * | 2012-06-22 | 2015-02-24 | 골든 바이오테크놀러지 코포레이션 | Methods and compositions for treating arteriosclerotic vascular diseases |
MX366970B (en) | 2012-07-03 | 2019-08-01 | Zeller Max Soehne Ag | Novel pharmacological use of cimicifuga extract. |
JP2014091706A (en) * | 2012-11-02 | 2014-05-19 | Kao Corp | Glp-1 secretion promoter |
KR101964841B1 (en) * | 2017-03-07 | 2019-08-07 | 주식회사 엘지생활건강 | Composition for relieving menopausal symptom |
KR101965849B1 (en) * | 2017-03-07 | 2019-04-04 | 주식회사 엘지생활건강 | Composition for relieving menopausal symptom comprising Tectorigenin 7-O-xylosylglucoside |
TWI761372B (en) * | 2017-09-22 | 2022-04-21 | 日商東洋新藥股份有限公司 | combination |
EP3906040A1 (en) | 2018-12-31 | 2021-11-10 | Max Zeller Söhne AG | Combination of cimicifuga and petasites extracts for anticancer therapy and prophylaxis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6330417A (en) * | 1986-07-23 | 1988-02-09 | Tsumura Juntendo Inc | Anti-allergic agent |
WO1997009056A1 (en) * | 1995-09-07 | 1997-03-13 | L'oreal | Extract of iridaceae and compositions containing such extract |
PL327617A1 (en) * | 1995-10-23 | 1998-12-21 | Zymogenetics Inc | Compositions for and methods of treating osseous insufficiency |
JPH09301884A (en) * | 1996-05-15 | 1997-11-25 | Ichimaru Pharcos Co Ltd | Testosterone 5 alpha-reductase inhibitor containing blackberry lily extract and alpha-hydroxyl acid and its application |
JPH107580A (en) * | 1996-06-15 | 1998-01-13 | Michio Yoshida | Collagenase inhibitor |
JP3665848B2 (en) * | 1996-09-18 | 2005-06-29 | 木村 幸代 | Fermented beverage of Himeogi dwarf bulb extract and method for producing the same |
DE19652183C1 (en) * | 1996-12-14 | 1998-02-12 | Schaper & Bruemmer Gmbh | Treating oestrogen-dependent tumour with Cimicifuga racemosa extract |
-
1998
- 1998-03-19 DE DE19812204A patent/DE19812204A1/en not_active Withdrawn
-
1999
- 1999-03-19 CZ CZ20002810A patent/CZ292684B6/en not_active IP Right Cessation
- 1999-03-19 KR KR1020007008724A patent/KR100623333B1/en not_active IP Right Cessation
- 1999-03-19 AT AT99913282T patent/ATE225182T1/en active
- 1999-03-19 BR BR9908256-0A patent/BR9908256A/en not_active IP Right Cessation
- 1999-03-19 PT PT99913282T patent/PT1064009E/en unknown
- 1999-03-19 HU HU0200921A patent/HU227694B1/en not_active IP Right Cessation
- 1999-03-19 WO PCT/EP1999/001860 patent/WO1999047149A1/en not_active Application Discontinuation
- 1999-03-19 RU RU2003137324/15A patent/RU2263505C2/en not_active IP Right Cessation
- 1999-03-19 ES ES99913282T patent/ES2184427T5/en not_active Expired - Lifetime
- 1999-03-19 PL PL99342486A patent/PL194096B1/en not_active IP Right Cessation
- 1999-03-19 MX MXPA00007986A patent/MXPA00007986A/en active IP Right Grant
- 1999-03-19 CA CA2321444A patent/CA2321444C/en not_active Expired - Fee Related
- 1999-03-19 CN CN03145494A patent/CN100581541C/en not_active Expired - Fee Related
- 1999-03-19 RU RU2000126476/15A patent/RU2228188C2/en not_active IP Right Cessation
- 1999-03-19 DE DE59902932T patent/DE59902932D1/en not_active Expired - Lifetime
- 1999-03-19 DK DK99913282T patent/DK1064009T4/en active
- 1999-03-19 TR TR2000/02686T patent/TR200002686T2/en unknown
- 1999-03-19 CN CNB998041238A patent/CN100444867C/en not_active Expired - Fee Related
- 1999-03-19 SE SE99913282T patent/SE1064009T4/en unknown
- 1999-03-19 EP EP99913282A patent/EP1064009B2/en not_active Expired - Lifetime
- 1999-03-19 AU AU31466/99A patent/AU755900C/en not_active Ceased
- 1999-03-19 JP JP2000536389A patent/JP2002506827A/en not_active Withdrawn
-
2001
- 2001-07-03 HK HK01104552A patent/HK1035660A1/en not_active IP Right Cessation
-
2010
- 2010-03-01 JP JP2010044419A patent/JP2010132699A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1064009T4 (en) | Use of extracts of iris plants and Cimicifuga racemosa and tectorigenin as estrogen-like organ selective drug without uterotropic effect | |
NO20006431L (en) | Composition to prevent and / or treat osteoporosis and changes due to menopausal syndrome | |
DK1370271T3 (en) | Process for the preparation of a matrix-containing plant preparation | |
DK0835120T3 (en) | Pharmaceutical compositions containing active ingredients based on herbs, process for preparing compositions | |
NO20012774D0 (en) | Preparation and method using essential plant oils | |
DK1112067T3 (en) | Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and / or organic pain syndromes | |
DK2211884T3 (en) | HYDROLYSISTS MADE BY PLANT EXTRACTS AND ANTIBACTERIAL AGENTS CONTAINING THE SAME | |
DK0847755T3 (en) | Application of an extract of cimicifuga racemosa | |
DK1687015T3 (en) | Compositions for the treatment of diseases of the oral cavity and upper respiratory tract | |
ATE318610T1 (en) | ORAL COMPOSITIONS FOR TREATING SCALP DISEASES | |
ES2195939T3 (en) | COMPOSITION FOR PREVENTION AND / OR TREATMENT OF CIRCULATORY DISORDERS THAT INCLUDES DERIVATIVES OF L-CARNITINE AND GINKGO BILOBA EXTRACTS. | |
JP2004091338A5 (en) | ||
TR200100637T2 (en) | New natural product derivatives | |
DK1183037T3 (en) | Compositions for modulating immune response and for treating inflammatory diseases | |
NO975177D0 (en) | Pharmaceutical compositions for the treatment of alcohol dependence | |
NO952601L (en) | Oligonucleotides for Inhibition of Expression of Isoprenyl Protein Transferases | |
ATE339216T1 (en) | MURRAYA KOENIGII EXTRACTS FOR TREATING ASTHMA | |
YU69395A (en) | Preparatons based on medical herbs | |
BR0104677A (en) | Homeopathic Formulation for the Prevention and Treatment of Menopause Disorders | |
MY148658A (en) | Pharmaceutical composition for the treatment and/or prevention of ulcer, inflammation, wound, hypertension and hyperalgesia | |
ZA200507842B (en) | Nutritional supplement | |
BR0002231A (en) | Natural medicine formulation |